Reports and Policy Briefs

EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy

Journal: Value in Health

Authors: S. Bhattacharyya, D. John, A. Thomas, P. Soni, A.B. Jesudian, A.A. Dashputre, G. Joseph

June 2023